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HCP who consented and provided a mobile phone number were sent a text message (or 'SMS') seven days after vaccination querying whether they had experienced any 'reaction, fever or illness' following vaccination.
A second SMS was sent 24 hours later to anyone who did not reply to the first message. HCP who responded "Yes" to either message were sent a link to a mobile phone survey to record the details of their AEFI. Those who opted not to complete the smart phone survey and those who did not reply to either SMS were telephoned to ascertain specifics of any AEFI via a standardised interview with a research nurse.
Both surveys were identical in content and asked whether the participant experienced fever, headache, fatigue, vomiting, rash, rigors, convulsions or swelling or pain at the injection site. Other reported potential side-effects were recorded verbatim/as written.
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Our findings demonstrate the feasibility of implementing a timely, resourceconserving, vaccine safety monitoring system among HCP each year during influenza vaccination season.
Previous methods to capture AEFI following IIV3 in HCP mainly include self-report paper questionnaires, which require significantly more time to capture, record and analyse the data. 4, 7, 8 Smartphone penetration in Australia was reported at 65% in 2013, making it a suitable market for the use of such technology. 8 In the same survey, smartphone use is reportedly less common in other countries such as the United Kingdom (62%) and the United States (56%), however overall there is increasing smartphone penetration globally, and in future the use of this technology has applications any time a new vaccine is introduced. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Financial Support:
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